Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Role of CAGE, a Novel Cancer/Testis Antigen, in Various Cellular Processes, Including Tumorigenesis, Cytolytic T Lymphocyte Induction, and Cell Motility

  • Kim, Young-Mi (School of Biological Sciences, College of Natural Sciences, Kangwon National University) ;
  • Jeoung, Doo-Il (School of Biological Sciences, College of Natural Sciences, Kangwon National University)
  • Published : 2008.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

A cancer-associated antigen gene (CAGE) was identified by serological analysis of a recombinant cDNA expression library (SEREX). The gene was identified by screening cDNA expression libraries of human testis and gastric cancer cell lines with sera from patients with gastric cancer. CAGE was found to contain a D-E-A-D box domain and encodes a putative protein of 630 amino acids with possible helicase activity. The CAGE gene is widely expressed in various cancer tissues and cancer cell lines. Demethylation plays a role in the activation of CAGE in certain cancer cell lines where the gene is not expressed. The functional roles of CAGE in tumorigenesis, the molecular mechanisms of CAGE expression, and cell motility are also discussed.

Keywords

References

  1. Baylin, S. B. and J. G. Herman. 2000. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet. 16: 168-174 https://doi.org/10.1016/S0168-9525(99)01971-X
  2. Baylin, S. B., M. Esteller, M. R. Rountree, K. E. Bachman, K. Schuebel, and J. G. Herman. 2001. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10: 687-692 https://doi.org/10.1093/hmg/10.7.687
  3. Bird, A. 1992. The essentials of DNA methylation. Cell 70: 5-8 https://doi.org/10.1016/0092-8674(92)90526-I
  4. Boel, P., C. Wildmann, M. L. Sensi, R. Brasseur, J. Renauld, P. Coulie, et al. 1995. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167-175 https://doi.org/10.1016/S1074-7613(95)80053-0
  5. Boon, T. and P. Van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183: 725-729 https://doi.org/10.1084/jem.183.3.725
  6. Boon, T., P. G. Coulie, B. J. Van den Eynde, and P. van der Bruggen. 2006. Human T cell responses against melanoma. Annu. Rev. Immunol. 24: 175-208 https://doi.org/10.1146/annurev.immunol.24.021605.090733
  7. Chang, E. J., H. J. Kim, J. Ha, H. J. Kim, J. Ryu, K. H. Park, U. H. Kim, Z. H. Lee, H. M. Kim, D. E. Fisher, and H. H. Kim. 2007. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J. Cell Sci. 120: 166-176 https://doi.org/10.1242/jcs.03310
  8. Chen, Y. T. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918
  9. Chen, Y. T., A. O. Gure, S. Tsang, E. Stockert, E. Jager, A. Knuth, and L. J. Old. 1998. Identification of multiple cancer/testis antigens by allogenic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA 95: 6919-6923
  10. Chen, Y. T., M. Scanlan, U. Sahin, O. Tureci, A. O. Gure, S. Tsang, et al. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918.
  11. Cho, B., H. Lee, S. Jeong, Y. J. Bang, H. J. Lee, K. S. Hwang, H. Y. Kim, Y. S. Lee, G. H. Kang, and D. I. Jeoung. 2003. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem. Biophys. Res. Commun. 307: 52-63 https://doi.org/10.1016/S0006-291X(03)01121-5
  12. Cho, B., Y. Lim, D. Y. Lee, S. Y. Park, H. Lee, W. H. Kim, H. Yang, Y. J. Bang, and D. I. Jeoung. 2002. Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem. Biophys. Res. Commun. 292: 715-726 https://doi.org/10.1006/bbrc.2002.6701
  13. Cook, A. C., A. F. Chambers, E. A. Turley, and A. B. Tuck. 2006. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy. J. Biol. Chem. 281: 24381-24389 https://doi.org/10.1074/jbc.M602694200
  14. Diala, E. S., M. S. C. Cheah, D. Rotwich, and R. M. Hoffman. 1983. Extent of DNA methylation in tumor cells. J. Natl. Cancer Inst. 71: 755-764
  15. Disis, M. L., E. Calenoff, G. McLaughlin, A. E. Murphy, W. Chen, B. Groner, M. Jeschke, N. Lydon, E. McGlynn, R. B. Livingston, R. Moe, and M. A. Cheever. 1994. Existent T-cell and antibody immunity to Her/neu protein in patients with breast cancer. Cancer Res. 54: 16-20
  16. Eden, S. and H. Cedar. 1994. Role of DNA methylation in the regulation of transcription. Curr. Opin. Genet. Dev. 4: 255-259 https://doi.org/10.1016/S0959-437X(05)80052-8
  17. Eichmuller, S., D. Usener, R. Dummer, A. Stein, D. Thiel, and D. Schadendorf. 2001. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc. Natl. Acad. Sci. USA 98: 629-634
  18. Esteller, M., O. G. Corn, S. B. Baylin, and J. G. Herman. 2001. A gene hypermethylation profile of human cancers. Cancer Res. 61: 3225-3229
  19. Feinberg, A. P. and B. Vogelstein. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92 https://doi.org/10.1038/301089a0
  20. Feinberg, A. P., C. W. Gehrke, K. C. Kuo, and M. Ehrlich. 1988. Reduced genomic 5-methylcytosine in human colonic neoplasia. Cancer Res. 48: 1159-1161
  21. Fuks, F., W. A. Burgers, A. Brehm, L. Hughes-Davies, and T. Kouzarides. 2000. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24: 88-91 https://doi.org/10.1038/71750
  22. Gomes, J. A., R. Amankwah, A. Powell-Richards, and H. S. Dua. 2004. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br. J. Ophthalmol. 88: 821-825 https://doi.org/10.1136/bjo.2003.027573
  23. Grunwald, C., M. Koslowski, T. Arsiray, K. Dhaene, M. Praet, A. Victor, A. Morresi-Hauf, M. Lindner, B. Passlick, H. A. Lehr, S. C. Schafer, G. Seitz, C. Huber, U. Sahin, and O. Tureci. 2006. Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. Int. J. Cancer 118: 2522-2528 https://doi.org/10.1002/ijc.21669
  24. Gure, A. O., N. K. Altorki, E. Stockert, M. Scanlan, L. J. Old, and Y. T. Chen. 1998. Human lung cancer antigens recognized by autologous antibodies: Definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res. 58: 1034-1041
  25. Haroon, Z. A., J. M. Hettasch, T. S. Lai, M. W. Dewhirst, and C. S. Greenberg. 1999. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 13: 1787-1795 https://doi.org/10.1096/fasebj.13.13.1787
  26. Hirling, H., M. Scheffner, T. Restle, and H. Stahl. 1989. RNA helicase activity associated with the human p68 protein. Nature 339: 562-564 https://doi.org/10.1038/339562a0
  27. Huang, S., K. D. Preuss, X. Xie, E. Regitz, and M. Pfreundschuh. 2002. Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol. Immunother. 51: 655-662 https://doi.org/10.1007/s00262-002-0320-4
  28. Itoh, K., C. D. Platsoucas, and C. M. Balch. 1988. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J. Exp. Med. 168: 1419-1441 https://doi.org/10.1084/jem.168.4.1419
  29. Iwata, T., T. Fujia, Y. Matsuzaki, T. Okada, H. Mochimaru, N. Susumu, et al. 2005. Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instabilitypositive endometrial cancer. Clin. Cancer Res. 119: 3949-3957
  30. Jager, D., M. Unkelbach, C. Frei, F. Bert, M. J. Scanlan, E. Jager, L. J. Old, Y. T. Chen, and A. Knuth. 2002. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun. 2: 5
  31. Jager, E., Y. T. Chen, J. Drijfhout, J. Karbach, M. Ringhoffer, D. Jager, M. Arand, H. Wada, Y. Noguchi, E. Stoockert, L. J. Old, and A. Knuth. 1998. Simultaneous humoral and immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA-2)-A2-binding peptide epitopes. J. Exp. Med. 187: 265-270 https://doi.org/10.1084/jem.187.2.265
  32. Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCP2 recruit histone deacetylases to repress transcription. Nat. Genet. 19: 187-191 https://doi.org/10.1038/561
  33. Khong, H. T., J. C. Yang, S. L. Topalian, R. M. Sherry, S. A. Mavroukakis, et al. 2004. Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen. J. Immunother. 27: 472-477 https://doi.org/10.1097/00002371-200411000-00007
  34. Kikuchi, R., H. Tsuda, Y. Kanai, T. Kasamatsu, K. Sengoku, S. Hirohashi, J. Inazawa, and I. Imoto. 2007. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res. 67: 7095-7105 https://doi.org/10.1158/0008-5472.CAN-06-4567
  35. Kim, H. R., M. A. Wheeler, C. M. Wilson, J. Iida, D. Eng, M. A. Simpson, J. B. McCarthy, and K. M. Bullard. 2004. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res. 64: 4569-4576 https://doi.org/10.1158/0008-5472.CAN-04-0202
  36. Kim, M. S., H. Y. Choi, Y. S. Choi, J. Kim, and Y. S. Kim. 2007. Optimized serological isolation of lung cancer-associated antigens from a yeast surface-expressed cDNA library. J. Microbiol. Biotechnol. 17: 993-1001
  37. Knoepfler, P. S. and R. N. Eisenman. 1999. Sin meets NuRD and other tails of repression. Cell 99: 447-450 https://doi.org/10.1016/S0092-8674(00)81531-7
  38. Kono, K., Y. Rongcun, J. Charo, F. Ichihara, E. Celis, A. Sette, et al. 1998. Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes. Int. J. Cancer 78: 202-208 https://doi.org/10.1002/(SICI)1097-0215(19981005)78:2<202::AID-IJC14>3.0.CO;2-C
  39. Labrecque, S., N. Naor, D. Thomson, and G. Matlashweski. 1993. Analysis of the anti-p53 antibody response in cancer patients. Cancer Res. 53: 3468-3471
  40. Laird, P. W., L. Jackson-Grusby, A. Fazeli, S. L. Dickinson, W. E. Jung, E. Li, R. A. Weinberg, and R. Jaenisch. 1995. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197-205 https://doi.org/10.1016/0092-8674(95)90329-1
  41. Laird, P. W. and R. Jaenisch. 1994. DNA methylation and cancer. Hum. Mol. Genet. 3: 1487-1495 https://doi.org/10.1093/hmg/3.suppl_1.1487
  42. Lee, S. B., I. H. Bae, Y. S. Bae, and H. D. Um. 2006. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J. Biol. Chem. 281: 36228-36235 https://doi.org/10.1074/jbc.M606702200
  43. Lee, S. Y. and D. Jeoung. 2007. The reverse proteomics for identification of tumor antigens. J. Microbiol. Biotechnol. 17: 879-890
  44. Lee, S. Y., Y. Obata, M. Yoshida, E. Stockert, B. Williamson, A. A. Jungbluth, Y. T. Chen, L. J. Old, and M. J. Scanlan. 2003. Immunomic analysis of human sarcoma. Proc. Natl. Acad. Sci. USA 100: 2651-2656
  45. Li, E., C. Beard, A. C. Forster, T. H. Bestor, and R. Jaenisch. 1993. DNA methylation, genomic imprinting, and mammalian development. Cold Spring Harbor Symp. Quant. Biol. 58: 297-305
  46. Li, E., C. Beard, and R. Jaenisch. 1993. Role for DNA methylation in genome imprinting. Nature 366: 362-365 https://doi.org/10.1038/366362a0
  47. Linder, P., P. F. Lasko, M. Ashburner, P. Leroy, P. J. Nielsen, K. Nishi, J. Scgnier, and P. P. Slonimski. 1989. Birth of the D-E-AD box. Nature 337: 121-122 https://doi.org/10.1038/337121a0
  48. Livingston, P. O., E. J. Natoli, M. J. Calves, E. Stockert, H. F. Oettgen, and L. J. Old. 1987. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. Proc. Natl. Acad. Sci. USA 84: 2911-2915
  49. Loriot, A., E. De Plaen, T. Boon, and C. De Smet. 2006. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J. Biol. Chem. 281: 10118-10126 https://doi.org/10.1074/jbc.M510469200
  50. Lunyak, V. V., R. Burgess, G. G. Prefontaine, C. Nelson, S. H. Sze, J. Chenoweth, P. Schwartz, P. A. Pevzner, C. Glass, G. Mandel, and M. G. Rosenfeld. 2002. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 98: 1747-1752
  51. Maa, M. C., J. C. Lee, Y. J. Chen, Y. J. Chen, Y. C. Lee, S. T. Wang, C. C. Huang, N. H. Chow, and T. H. Leu. 2007. Eps8 facilitates cellular growth and motility of colon cancer cells by increasing the expression and activity of focal adhesion kinase. J. Biol. Chem. 282: 19399-19409 https://doi.org/10.1074/jbc.M610280200
  52. Martelange, V., C. De Smet, E. De Plaen, C. Lurquin, and T. Boon. 2000. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res. 60: 3848-3855
  53. Miyahara, Y., H. Naota, L. Wang, A. Hiasa, M. Goto, M. Watanabe, S. Kitano, S. Okumura, T. Takemitsu, A. Yuta, Y. Majima, F. A. Lemonnier, T. Boon, and H. Shiku. 2005. Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Clin. Cancer Res. 11: 5581-5589 https://doi.org/10.1158/1078-0432.CCR-04-2585
  54. Mummert, M. E., D. I. Mummert, L. Ellinger, and A. Takashima. 2003. Functional roles of hyaluronan in B16-F10 melanoma growth and experimental metastasis in mice. Mol. Cancer Ther. 2: 295-300
  55. Muul, L. M., P. J. Spiess, E. P. Director, and S. A. Rosenberg. 1987. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 138: 989-995
  56. Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding proteins MeCP2 involves a histone deacetylase complex. Nature 393: 386-389 https://doi.org/10.1038/30764
  57. Obata, Y., T. Takahashi, J. Sakamoto, H. Tamaki, S. Tominaga, N. Hamajima, et al. 2000. SEREX analysis of gastric cancer antigens. Cancer Chemother. Pharmacol. 46: S37-S42 https://doi.org/10.1007/PL00014048
  58. Oehlrich, N., G. Devitt, M. Linnebacher, Y. Schwitalle, S. Grosskinski, S. Stevanovic, and M. Zöller. 2005. Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma. Int. J. Cancer 117: 256-264 https://doi.org/10.1002/ijc.21200
  59. Okada, T., M. Akada, T. Fujita, T. Iwata, Y. Goto, K. Kido, et al. 2006. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers. Clin. Cancer Res. 12: 191-197 https://doi.org/10.1158/1078-0432.CCR-05-1206
  60. Ottaviani, S., Y. Zhang, T. Boon, and P. van der Bruggen. 2005. A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells. Cancer Immunol. Immunother. 54: 1214-1220 https://doi.org/10.1007/s00262-005-0705-2
  61. Quan, G., J. Y. Choi, D. S. Lee, and S. C. Lee. 2005. TGFbeta1 up-regulates transglutaminase two and fibronectin in dermal fibroblasts: A possible mechanism for the stabilization of tissue inflammation. Arch. Dermatol. Res. 297: 84-90 https://doi.org/10.1007/s00403-005-0582-8
  62. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4: 321-327 https://doi.org/10.1038/nm0398-321
  63. Sahin, U., O. Türeci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, et al. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92: 11810-11813
  64. Scanlan, M. J., A. O. Gure, A. A. Jungbluth, L. J. Old, and Y. T. Chen. 2002. Cancer/testis antigens: An expanding family of targets for cancer immunotherapy. Immunol. Rev. 188: 22-32 https://doi.org/10.1034/j.1600-065X.2002.18803.x
  65. Shim, E., H. Shim, J. Bae, H. Lee, and D. Jeoung. 2006. CAGE displays oncogenic potential and induces cytolytic T lymphocyte activity. Biotechnol. Lett. 28: 515-522 https://doi.org/10.1007/s10529-006-0008-5
  66. Shim, H., H. Lee, and D. Jeoung. 2006. Cancer/testis antigen cancer-associated gene (CAGE) promotes motility of cancer cells through activation of focal adhesion kinase (FAK). Biotechnol. Lett. 28: 2057-2063 https://doi.org/10.1007/s10529-006-9190-8
  67. Sigalotti, L., E. Fratta, S. Coral, S. Tanzarella, R. Danielli, F. Colizzi, E. Fonsatti, C. Traversari, M. Altomonte, and M. Maio. 2004. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine. Cancer Res. 64: 9167-9171 https://doi.org/10.1158/0008-5472.CAN-04-1442
  68. Smith, S. S. 1994. Biological implications of the mechanism of action of human DNA (cytosine-5) methyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 49: 65-111 https://doi.org/10.1016/S0079-6603(08)60048-3
  69. Stephens, P., P. Grenard, P. Aeschlimann, M. Langley, E. Blain, R. Errington, D. Kipling, D. Thomas, and D. Aeschlimann. 2004. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J. Cell Sci. 117: 3389-3403 https://doi.org/10.1242/jcs.01188
  70. Strathdee, G., T. L. Holyoake, A. Sim, A. Parker, D. G. Oscier, J. V. Melo, S. Meyer, T. Eden, A. M. Dickinson, J. C. Mountford, H. G. Jorgensen, R. Soutar, and R. Brown. 2007. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin. Cancer Res. 13: 5048-5055 https://doi.org/10.1158/1078-0432.CCR-07-0919
  71. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12: 599-606 https://doi.org/10.1101/gad.12.5.599
  72. Tate, P. H. and A. P. Bird. 1993. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 3: 226-231 https://doi.org/10.1016/0959-437X(93)90027-M
  73. Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumor progression. Nat. Rev. Cancer 2: 442-454 https://doi.org/10.1038/nrc822
  74. Traversari, C., P. van der Bruggen, I. F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, et al. 1992. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176: 1453-1457 https://doi.org/10.1084/jem.176.5.1453
  75. Udabage, L., G. R. Brownlee, M. Waltham, T. Blick, E. C. Walker, P. Heldin, S. K. Nilsson, E. W. Thompson, and T. J. Brown. 2005. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res. 65: 6139-6150 https://doi.org/10.1158/0008-5472.CAN-04-1622
  76. Van den Bruggen, P., C. Travesari, P. Chomez, C. Lurquin, E. De Plaen, B. Van der Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes. Science 254: 1643-1647 https://doi.org/10.1126/science.1840703
  77. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182: 689-698 https://doi.org/10.1084/jem.182.3.689
  78. Wischnewski, F., K. Pantel, and H. Schwarzenbach. 2006. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol. Cancer Res. 4: 339-349 https://doi.org/10.1158/1541-7786.MCR-05-0229
  79. Wischnewski, F., O. Friese, K. Pantel, and H. Schwarzenbach. 2007. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters. Mol. Cancer Res. 5: 749-759 https://doi.org/10.1158/1541-7786.MCR-06-0364